Regeneron falls after appeals court ruling in Eylea case (update)
Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 3% after the company's loss against Amgen (AMGN) and others in a patent case ...
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Regeneron Pharmaceuticals Inc. closed 44.49% short of its 52-week high of $1,211.20, which the company reached on August 27th ...
BioSpace5d
Regeneron Loses Appeal to Block Amgen’s Eylea Biosimilar
The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...
Regeneron Pharmaceuticals Has Lost Its Way, But Can It Find It Again?
Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Regeneron Pharmaceuticals Inc. closed 45.10% below its 52-week high of $1,211.20, which the company reached on August 27th.
Hosted on MSN8d
Jim Cramer On Regeneron Pharmaceuticals Inc. (REGN) – “I Want You to Own It”
We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take ...
FINAL REGN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Regeneron Therapeutics, Inc. Investors to Join the Class Action Lawsuit
NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Regeneron down 3% after appeals court decision in Amgen patent fight
EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...
THE 2025 DERMATOLOGY FOUNDATION-SKIN OF COLOR SOCIETY COLLABORATIVE MID-CAREER AWARD SPONSORED BY SANOFI AND REGENERON IS BESTOWED O…
The Dermatology Foundation (DF) and the Skin of Color Society (SOCS) announce that Crystal U. Aguh, MD, FAAD, is the 2025 ...
Jones Financial Companies Lllp Has $578,000 Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...
Melody Hong, of General Douglas MacArthur High School, places sixth in Regeneron Science Talent Search
The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...
Seeking Alpha8d
Regeneron falls after appeals court ruling in Eylea case (update)
Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 1.6% after the company's loss against Amgen (NASDAQ:AMGN) in a patent case over Regeneron's blockbuster Eylea drug was affirmed by an appeals court.